6 Firms Guide Advanz Pharma's $846M Nordic Capital Deal
Advanz Pharma said Wednesday it's agreed to be bought by European investment firm Nordic Capital in a deal valuing the specialty pharmaceutical group at $846 million that was guided by six...To view the full article, register now.
Already a subscriber? Click here to view full article